GGrantIndex
Sort

172,184 grants matching inflammation

Anandamide Transport Inhibitors

$769,581
Dale G Deutsch · State University New York Stony Brook · R01 · FY2013 · DA

Animal Core

$769,575
David A Stoltz · University Of Iowa · P01 · FY2013 · HL

Pathways of vertical Zika virus transmission in nonhuman primate pregnancy

$769,551
Thaddeus G Golos · University Of Wisconsin-Madison · R01 · FY2018 · AI

Effect of obesity and diabetes in regulating pulmonary and extra-pulmonary anti-viral immune responses

$769,522
Kamal Mohan Khanna · New York University School Of Medicine · R01 · FY2024 · DK

Regulation of mucosal immunity by neuronal pathways

$769,513
David Artis · Weill Medical Coll Of Cornell Univ · U01 · FY2021 · AI

Xenon MRI in Pulmonary Hypertension

$769,506
Sudarshan K Rajagopal · Duke University · R01 · FY2022 · HL

Risk stratification in pulmonary arterial hypertension: Intersection of OMICs and longitudinal phenotypes through the PAH Biobank

$769,444
William C Nichols · Cincinnati Childrens Hosp Med Ctr · R01 · FY2024 · HL

The Role of Adaptor Protein Disabled-2 in Maintaining Endothelial Cell Function in Atherosclerosis

$769,426
Hong Chen · Boston Children'S Hospital · R01 · FY2023 · HL

How SAMHD1 regulates HIV-1 innate immunity and viral gene expression

$769,414
Li Wu · University Of Iowa · R01 · FY2025 · AI

An integrated approach to predict and improve the outcomes of lung injury

$769,398
Maurizio Franco Cereda · University Of Pennsylvania · R01 · FY2018 · HL

Cocaine use, viral suppression and precursors of stroke in HIV infection

$769,350
Elise D Riley · University Of California, San Francisco · R01 · FY2024 · DA

Enhancing Inflammation Resolution in Atherosclerosis via Targeted Nanoparticle-Mediated Delivery of Biologics

$769,326
Ira A Tabas · Columbia University Health Sciences · R01 · FY2016 · HL

Protozoan Population Genetics and Inflammation

$769,313
Michael Grigg · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI

Children's Environmental Health Center

$769,302
University Of Southern California · P01 · FY2004 · ES

Immune Checkpoints in Acute Respiratory Distress Syndrome (IC-ARDS)

$769,298
Carmen R Mikacenic · Benaroya Research Inst At Virginia Mason · R01 · FY2020 · HL

Chronic Renal Insufficiency in NAPRTCS Patients

$769,296
Bradley Alan Warady · Children'S Mercy Hosp (Kansas City, Mo) · U01 · FY2007 · DK

Preclinical studies of a Cryptococcus vaccine for AIDS patients

$769,284
Jennifer K. Lodge · Duke University · R01 · FY2025 · AI

Targeting the PD - 1 pathway to eradicate SIV/HIV

$769,283
Rafick-Pierre Sekaly · University Of California, San Francisco · U19 · FY2013 · AI

Molecular Imaging CCR2 Lung Inflammation and Fibrosis

$769,278
Steven Brody · Washington University · R01 · FY2022 · HL

Generation of highly differentiated NK cells to synergize with broadly neutralizing antibodies to establish viral control in absence of ART

$769,220
Mirko Paiardini · Emory University · R01 · FY2025 · AI

Biobehavioral mechanisms linking personality to health in midlife

$769,188
Stephen B Manuck · University Of Pittsburgh At Pittsburgh · R01 · FY2016 · AG

Targeting mediators of oxidative stress to limit hyperinflammatory cell death modalities during Mycobacterium tuberculosis infection

$769,168
Robert Owen Watson · Vanderbilt University Medical Center · R01 · FY2025 · AI

Developmental origins and early detection of ADHD and dysregulatory psychopathology

$769,119
Elinor L. Sullivan · Oregon Health & Science University · R01 · FY2024 · MH

Meningeal Immunity and Viral Neuropathogenesis

$769,115
Michael S. Diamond · Washington University · R01 · FY2024 · AI

Meningeal Immunity and Viral Neuropathogenesis

$769,115
Michael S. Diamond · Washington University · R01 · FY2025 · AI